Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.

Epiroprim (EPM; Ro 11-8958) is a new selective inhibitor of microbial dihydrofolate reductase. EPM displayed excellent activity against staphylococci, enterococci, pneumococci, and streptococci which was considerably better than that of trimethoprim (TMP). EPM was also active against TMP-resistant s...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Locher, H H, Schlunegger, H, Hartman, P G, Angehrn, P, Then, R L
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1996
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163334/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8726004/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.6.1376
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!